术前多西环素不能减少肩关节置换术中的痤疮丙酸杆菌
这项随机对照试验纳入56例肩关节置换患者,比较标准头孢唑林与多西环素联合头孢唑林对皮肤及深部组织痤疮丙酸杆菌培养阳性的影响。结果显示两组培养阳性率无显著差异(头孢唑林组37% vs 联合组38%,p=0.99),且无多西环素相关不良事件。作者认为预防性静脉加用覆盖痤疮丙酸杆菌的抗生素可能不是减少术后及假体周围肩关节感染的有效方法。
要点
- 多西环素联合头孢唑林组与单用头孢唑林组的痤疮丙酸杆菌培养阳性率无显著差异(38% vs 37%,p=0.99)。
- 培养阳性率最高的部位为皮肤(30%),其次为真皮组织(20%)和盂肱关节(5%)。
- 培养阳性组患者较阴性组更年轻(64.9±7.7 vs 69.4±7.7岁,p=0.041)。
核心结论
- 在肩关节置换术中,多西环素未显著降低皮肤、真皮或盂肱关节的痤疮丙酸杆菌培养阳性率。
- 作者认为,预防性静脉加用覆盖痤疮丙酸杆菌的抗生素可能不是减少术后及假体周围肩关节感染的有效方法。
研究设计与样本
- 随机对照试验,纳入56例计划行肩关节置换术的患者,随机接受标准围手术期头孢唑林或头孢唑林联合多西环素。
- 取皮肤边缘组织、浅层真皮组织拭子和盂肱关节拭子进行培养,所有培养维持14天以检测痤疮丙酸杆菌。
主要发现
- 56例患者中21例(38%)至少1次培养痤疮丙酸杆菌阳性。
- 头孢唑林单药组27例中10例(37%)阳性,多西环素联合头孢唑林组29例中11例(38%)阳性,两组无显著差异(p=0.99)。
- 培养阳性样本最多来自皮肤(30%),其次为真皮组织(20%)和盂肱关节(5%)。
- 培养阳性组较阴性组更年轻(平均年龄64.9±7.7 vs 69.4±7.7岁,p=0.041),男性比例更高(16/21 [76%] vs 17/35 [49%],p=0.053),Charlson合并症指数更低(3.35±1.3 vs 4.09±1.4,p=0.051)。
- 培养阳性组与阴性组在BMI(p=0.446)或关节置换类型上无显著差异,解剖型肩关节置换29例中8例阳性,反式肩关节置换27例中13例阳性(p=0.280)。
临床怎么用
- 作者认为,预防性静脉加用覆盖痤疮丙酸杆菌的抗生素可能不是减少术后及假体周围肩关节感染的有效方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Propionibacterium acnes (P. acnes) is the most common bacteria associated with infection after shoulder arthroplasty. These bacteria can be grown on culture of skin after standard preoperative skin preparation and antibiotics. The purpose of this study was to determine whether adding preoperative intravenous doxycycline reduces the prevalence of positive P. acnes cultures of skin and deep tissues at the time of prosthetic joint implantation during shoulder arthroplasty. METHODS: This was a randomized controlled trial. An a priori power analysis determined that a sample size of 56 patients was necessary. Patients scheduled to undergo shoulder arthroplasty were randomized to receive either standard perioperative cefazolin or a combination of doxycycline and cefazolin. Tissue specimens for culture were then taken from the skin edge, and swabs of the superficial dermal tissue and glenohumeral joint were obtained. All cultures were maintained for 14 days to allow for P. acnes detection. Groups were compared to determine if the addition of doxycycline reduced the rate of culture positivity. RESULTS: Fifty-six patients were enrolled and randomized. Twenty-one (38%) had ≥1 positive cultures for P. acnes, with no significant difference between the group treated with cefazolin alone (10 [37%] of 27 patients) and the combined doxycycline and cefazolin group (11 [38%] of 29 patients) (p = 0.99). The greatest numbers of culture-positive samples were obtained from the skin (30%), followed by dermal tissue (20%) and the glenohumeral joint (5%). Patients who had ≥1 positive cultures were younger than those who did not (mean age [and standard deviation], 64.9 ± 7.7 versus 69.4 ± 7.7 years; p = 0.041), had a greater tendency to be male (16 [76%] of 21 versus 17 [49%] of 35; p = 0.053), and had a lower Charlson Comorbidity Index (3.35 ± 1.3 versus 4.09 ± 1.4; p = 0.051). There were no significant differences between the culture-positive and culture-negative groups in terms of body mass index (BMI) (p = 0.446) or arthroplasty type, with positive cultures found for 8 of the 29 anatomic shoulder arthroplasty procedures compared with 13 of the 27 reverse shoulder arthroplasty procedures (p = 0.280). There were no doxycycline-related adverse events. CONCLUSIONS: In this randomized controlled trial, doxycycline did not significantly decrease P. acnes culture positivity of the skin, dermis, or glenohumeral joint of patients undergoing shoulder arthroplasty. The addition of prophylactic intravenous antibiotics to cover P. acnes may not be an effective method to reduce postoperative and periprosthetic shoulder joint infections. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
引用
- Rao AJ, Chalmers PN, Cvetanovich GL, et al. Preoperative Doxycycline Does Not Reduce Propionibacterium acnes in Shoulder Arthroplasty. J Bone Joint Surg Am. 2018. PMID: 29870447. doi:10.2106/JBJS.17.00584
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。